Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitin-associated protein 1 like (UBAP1L) is a protein encoded by the UBAP1L gene located on chromosome 15. It is predicted to function as an adaptor protein with ubiquitin binding activity and may participate in ubiquitin-dependent protein catabolic processes through multivesicular body sorting. UBAP1L is primarily expressed in the retina, particularly in photoreceptors and retinal pigment epithelium, implicating its importance in retinal biology[1][2][4]. Pathogenic biallelic variants in UBAP1L cause autosomal recessive forms of inherited retinal degeneration, including rod-cone and cone-rod dystrophies. The precise molecular function is not fully elucidated, but the gene product is thought to act in the retina through its ubiquitin-associated domain[2][4]. There are no known drugs or therapeutic compounds specifically interacting with UBAP1L, nor is it considered an established therapeutic target at present.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin-associated protein 1 like (UBAP1L).